Hypoxia-inducible factors and hypoxic cell death in tumour physiology

References

• Hockel M, Schlenger K, Hockel S, Aral B, Schaffer U, Vaupel P. Tumor hypoxia in pelvic recurrences of cervical cancer. Int J Cancer 1998;79:365–9.
   PubMed Web of Science ®Google Scholar
• Stadler P, Becker A, Feldmann HJ, Hansgen G, Dunst J, Wurschmidt F, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 1999;44:749–54.
   PubMed Web of Science ®Google Scholar
• Knowles HJ, Harris AL. Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res 2001;3:318–22.
   PubMed Web of Science ®Google Scholar
• Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38–47.
   PubMed Web of Science ®Google Scholar
• Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68–72.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gawlinski ET. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathe-matical models. Cancer Res 2003;63:3847–54.
   PubMed Web of Science ®Google Scholar
• Kajstura J, Cheng W, Sarangaraj an R, Li P, Li B, Nitahara JA, et al. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol 1996;271:H1215–28.
   PubMed Web of Science ®Google Scholar
• Webster KA, Discher DJ, Kaiser S, Hernandez 0, Sato B, Bishopric NH. Hypoxia-activated apoptosis of cardiac myo-cytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 1999;104: 239–52.
   Google Scholar
• Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266–76.
   PubMed Web of Science ®Google Scholar
• Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002;62:2493–7.
   PubMed Web of Science ®Google Scholar
• Tomes L, Emberley E, Niu Y, Troup S, Pastorek J, Strange K, et al. Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res Treat 2003;81:61–9.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Regulation of mammalian 02 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15: 551–78.
   PubMed Web of Science ®Google Scholar
• Maynard MA, Qi H, Chung J, Lee EH, Kondo Y, Hara S, et al. Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J Biol Chem 2003;278:11032–40.
   PubMed Web of Science ®Google Scholar
• Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998;92:2260–8.
   PubMed Web of Science ®Google Scholar
• Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular 02 tension. Proc Natl Acad Sci USA 1995; 92:5510–4.
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VI-IL targets hypoxia-inducible factors for oxygen-dependent pro-teolysis. Nature 1999;399:271–5.
   PubMed Web of Science ®Google Scholar
• Bruick RK, McKnight SL. A conserved family of proly1-4-hydroxylases that modify HIF. Science 2001;294:1337–40.
   PubMed Web of Science ®Google Scholar
• Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107: 43–54.
   Google Scholar
• O'Rourke JF, Dachs GU, Gleadle JM, Maxwell PH, Pugh CW, Stratford I J, et al. Hypoxia response elements. Oncol Res 1997;9:327–32.
   PubMed Web of Science ®Google Scholar
• Sowter HM, Ferguson M, Pym C, Watson P, Fox SB, Han C, et al. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade. J Pathol 2003;201:573–80.
   PubMed Web of Science ®Google Scholar
• Ryan HE, Lo J, Johnson RS. H1F-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17: 3005–15.
   Google Scholar
• Kotch LE, Iyer NV, Laughner E, Semenza GL. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999;209:254–67.
   PubMed Web of Science ®Google Scholar
• Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA 2000;97:8386–91.
   PubMedGoogle Scholar
• Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002;8:702–10.
   PubMed Web of Science ®Google Scholar
• Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The fresponsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998;12: 3320–4.
   Google Scholar
• Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003;23: 9361–74.
   Google Scholar
• Hara S, Hamada J, Kobayashi C, Kondo Y, Imura N. Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Com-mun 2001;287: 808–13.
   Google Scholar
• Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001; 414:550–4.
   PubMed Web of Science ®Google Scholar
• Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9:677–84.
   PubMed Web of Science ®Google Scholar
• Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protoonco-gene. Cancer Cell 2003;3:347–61.
   PubMed Web of Science ®Google Scholar
• Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, et al. Hypoxia inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 2000;60:4010–5.
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford I J, et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angio-genesis and tumor growth. Proc Natl Acad Sci USA 1997;94: 8104–9.
   Google Scholar
• Erez N, Milyavsky M, Eilam R, Shats I, Goldfinger N, Rotter V. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) sup-presses hypoxia-inducible factor-1alpha activation and inhi-
   Google Scholar
• Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angio-
   Google Scholar
• Halterman MW, Miller CC, Federoff HJ. Hypoxia-inducible 36. Mack FA, Rathmell WK, Arsham AM, Gnarra J, Keith B, Simon MC. Loss of pVHL is sufficient to cause HIF dysregu-
   Google Scholar
• Mack FA, Rathmell WK, Arsham AM, Gnarra J, Keith B, Simon MC. Loss of pVHL is sufficient to cause HIF dysregu-lation in primary cells but does not promote tumor growth. Cancer Cell 2003;3:75–88.
   PubMed Web of Science ®Google Scholar
• Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, et al. The hypoxic response of tumors is dependent on their
   Google Scholar
• Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. HIF-1-dependent regulation of hypoxic induction of the
   Google Scholar
• Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. Identification of novel hypoxia-dependent and independent target genes of the von Hippel-Lindau (VHL) tumour
   Google Scholar
• Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000;60:883–7.
   PubMed Web of Science ®Google Scholar
• Denko NC, Fontana LA, Hudson KM, Sutphin PD, Ray-chaudhun S, Altman R, et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 2003; 22:5907–14.
   Google Scholar
• Rajah R, Valentims B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-betal on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997;272: 12181–8.
   Google Scholar
• Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996.
   Google Scholar
• Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Jr, Giaccia AJ. Hypoxia induces accumulation of p53 protein, hut activation of a Gl-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994;14: 6264–77.
   Google Scholar
• Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 2001;29:684–8.
   PubMed Web of Science ®Google Scholar
• An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998;392:405–8.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Tomida A, Tsuruo T. Dephosphorylated hypoxia-inducible factor lalpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 2001;20: 5779–88.
   Google Scholar
• Wenger RH, Camenisch G, Desbaillets I, Chilov D, Gassmann M. Up-regulation of hypoxia-inducible factor-1alpha is not Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97: 9082–7.
   Google Scholar
• Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000;20:5454–68.
   PubMed Web of Science ®Google Scholar
• Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, et al. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondnal sites. J Biol Chem 2000;275:1439–48.
   PubMedGoogle Scholar
• Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97:9082–7.
   PubMed Web of Science ®Google Scholar
• Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003;22: 4734–44.
   Google Scholar
• Kim JY, Park JH. ROS-dependent caspase-9 activation in hypoxic cell death. FEBS Lett 2003;549:94–8.
   PubMed Web of Science ®Google Scholar
• Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC, et al. The E1B 19K/Bc1-2-binding protein Nip3 is a dimeric mito-chondrial protein that activates apoptosis. J Exp Med 1997; 186:1975–83.
   PubMed Web of Science ®Google Scholar
• Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, et al. Noxa, a BH3-only member of the Bc1-2 family and candidate mediator of p53-induced apoptosis. Science 2000;288:1053–8.
   PubMed Web of Science ®Google Scholar
• Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001;93:1337–43.
   PubMed Web of Science ®Google Scholar
• Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Suen LF, et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA 1998;95:10188–93.
   PubMedGoogle Scholar
• Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, et al. Correlation between insulin-like growth factor-binding pro-tein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Clin Cancer Res 2002;8: 3669–75.
   PubMed Web of Science ®Google Scholar
• Parkkila S, Rajaniemi H, Parkkila AK, Kivela J, Waheed A, Pastorekova S, et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 2000;97:2220–4.
   PubMed Web of Science ®Google Scholar
• Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bc1-2 family protein BNIP3. Proc Natl Acad Sci USA 2002; 99:12825–30.
   PubMed Web of Science ®Google Scholar
• Saitoh Y, Ouchida R, Miwa N. Bc1-2 prevents hypoxia/ reoxygenation-induced cell death through suppressed genera-tion of reactive oxygen species and upregulation of Bc1-2 proteins. J Cell Biochem 2003;90: 914–24.
   Google Scholar
• Zhivotovsky B. Apoptosis, necrosis and between. Cell Cycle 2004;3:64–6.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J, Yamabe K, et al. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bc1-2 and Bcl-XL. Cancer Res 1996;56:2161–6.
   PubMed Web of Science ®Google Scholar
• Steinbach JP, Wolburg H, Klumpp A, Probst H, Weller M. Hypoxia induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death. Cell Death Differ 2003;10:823–32.
   Google Scholar
• Tatsumi T, Shiraishi J, Keira N, Akashi K, Mano A, Yamanaka S, et al. Intracellular ATP is required for mito-chondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc Res 2003;59:428–40.
   PubMed Web of Science ®Google Scholar
• Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23–8.
   PubMed Web of Science ®Google Scholar
• Yuan J, Narayanan L, Rockwell S, Glazer PM. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 2000;60: 4372–6.
   PubMed Web of Science ®Google Scholar
• Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323–31.
   PubMed Web of Science ®Google Scholar
• Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS. Effect of p53 status on tumor response to antiangiogenic therapy. Science 2002;295: 1526–8.
   Google Scholar
• Hanafusa T, Yumoto Y, Nouso K, Nakatsukasa H, Onishi T, Fujikawa T, et al. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett 2002;176:149–58.
   PubMedGoogle Scholar
• Kumar CC. Signaling by integrin receptors. Oncogene 1998; 17:1365–73.
   PubMed Web of Science ®Google Scholar
• Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298–302.
   PubMed Web of Science ®Google Scholar
• Oehler MK, Norbury C, Hague S, Rees MC, Bicknell R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bc1-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene 2001;20: 2937–45.
   Google Scholar